Search for testicular cancer gene hits dead-end

Cell Cycle

Volumn 4, Issue 9, 2005, Pages 1136-1138

  Matin, Angabin ^a   Nadeau, Joseph H ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dead end; Promordial germ cells; Ter; Testicular germ cell tumors

Indexed keywords

CANCER GENETICS; FETUS DEVELOPMENT; GENE MUTATION; GENETIC REGULATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIMORDIAL GERM CELL; SEQUENCE ANALYSIS; SHORT SURVEY; TESTIS; TESTIS CANCER;

EID: 25444503969     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.9.1992     Document Type: Short Survey

References (42)

1. Ginsburg M, Snow MH and McLaren A. Primordial germ cells in the mouse embryo during gastrulation. Development 1990; 110:521-8.
2. McLaren A. Primordial germ cells in the mouse. Dev Biol 2003; 262:1-15.
3. Coffigny H, Bourgeois C, Ricoul M, Bernardino J, Vilain A, Niveleau A, Malfoy B and Dutrillaux B. Alterations of DNA methylation patterns in germ cells and Sertoli cells from developing mouse testis. Cytogenet Cell Genet 1999; 87:175-81.
4. Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, Walter J and Surani MA. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002; 117:15-23.
5. Donovan PJ and de Miguel MP. Turning germ cells into stem cells. Curr Opin Genet Dev 2003; 13:463-71.
6. Allegrucci C, Thurston A, Lucas E and Young L. Epigenetics and the germline. Reproduction 2005; 129:137-49-
7. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE and Fraumeni JF, Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995; 87:175-82.
8. Oosterhuis JW and Looijenga LHJ. Testicular germ-cell tumours in a broader perspective. Nature Rev Cancer 2005; 5:210-22.
9. United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and excercise. BMJ 1994; 308:1393-99.
10. Tollerud DJ, Blattner WA, Fraser MC, Brown LM, Pottern L, Shapiro E, Kirkemo A, Shawker TH, Javadpour N, O'Connell K, Stutzman RE and Fraumeni JF. Familial testicular cancer and urogenital developmental anomalies. Cancer 1985; 55:1849-54.
11. Looijenga LHJ, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen, EJ, Weber, RF, Wolffenbuttel K.P, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G and Oosterhuis JW. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63:2244-50.
12. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks, JD, Andrews PW, Brown PO and Thomson JA. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA. 2003; 100:13350-55.
13. Izquierdo MA, Van der Valk P, Van Ark-Otte J, Rubio G, Germa-Lluch JR, Ueda R, Scheper RJ., Takahashi T and Giaccone G. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol 1995; 177:253-8.
14. Tian Q, Frierson HFJ, Krystal GW and Moskaluk CA. Activating c-kit gene mutations in germ cell tumors. Am J Pathol 1999; 154:1643-47.
15. Looijenga LHJ, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fossa SD and Oosterhuis JW. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003; 63:7674-78.
16. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ and Weinberg RA. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996; 384:470-4.
17. Murty VV, Houldsworth J, Baldwin S, Reuter V, Hunziker W, Besmer P, Bosl G and Chaganti RS. Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci USA 1992; 89:11006-10.
18. Looijenga LH, Zafarana G, Grygalewicz B, Summersgill B, Debiec-Rychter M, Veltman J, Schoenmakers EF, Rodriguez S, Jafer O, Clark J, van Kessel AG, Shipley J, van Gurp RJ, Gillis AJ and Oosterhuis JW. Role of gain of 12p in germ cell tumour development. Apmis 2003; 111:161-71 (discussion 172-3).
19. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossa SD, Tucker K, Donald J, Collins F, Friedlander M, Hogg D, Goss P, Heidenreich A, Ormiston W, Daly PA, Forman D, Oliver TD, Leahy M, Huddart R, Cooper CS, Bodmer JG, Easton DF, Stratton MR and Bishop DT. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 2000; 24:197-200.
20. Stevens LC and Hummel KP. A description of spontaneous congenital testicular teratomas in strain 129 mice. J Natl Cancer Inst 1957; 18:719-747.
21. Stevens LC. Experimental production of testicular teratomas in mice. Proc Natl Acad Sci USA 1964; 52:654-61.
22. Stevens LC. Experimental production of testicular teratomas in mice of strain 129, A/He and their F1 hybrids. J Natl Cancer Inst 1970; 44:923-29.
23. Stevens LC. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 1967; 38:549-52.
24. Stevens LC. Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J Natl Cancer Inst 1966; 37:859-67.
25. Stevens LC. Environmental influence on experimental teratocarcinogenesis in testes of mice. J Exp Zool 1970; 174:407-14.
26. Stevens LC. A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 1973; 50:235-42.
27. Stevens LC. Testicular teratomas in fetal mice. J Natl Cancer Inst 1962; 28:247-67.
28. Stevens LC. In: Silver L, Martin G, Strickland S, eds. Cold Spring Harbor Conferences on Cell Proliferation: Teratocarcinoma Stem Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1983. p. 23-36.
29. Wobus AM and Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005; 85:635-78.
30. Stevens LC. The biology of teratomas. Adv Morphog 1967; 6:1-31.
31. Stevens LC. & Mackensen JA. Genetic and environmental influences on teratocarcinogenesis in mice. J Natl Cancer Inst 1961; 27: 443-53.
32. Matin A, Collin GB, Asada Y, Varnum D and Nadeau JH. Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain. Nat Genet 1999; 23: 237-40.
33. Nadeau JH, Singer JB, Matin A and Lander ES. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 2000; 24: 221-5.
34. Youngren KK, Nadeau JH and Matin A. Testicular cancer susceptibility in the 129.MOLF-Chr 19 mouse strain: additive effects, gene interactions and epigenetic modifications. Hum Mol Genet 2003; 12: 389-98.
35. Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman, SD, Boswell HS and Donovan PJ. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 1991; 352:809-11.
36. Lam M-YJ, Youngren KK and Nadeau JH. Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice. Genetics 2004; 166:925-33.
37. Asada Y, Varnum DS, Frankel WN and Nadeau JH. A mutation in the Ter gene causing increased susceptibility to testicular teratomas maps to mouse chromosome 18. Nat Genet 1994; 6: 363-8.
38. Sakurai T, Katoh H, Moriwaki K, Noguchi T and Noguchi M. The ter primordial germ cell deficiency mutation maps near Grl-1 on mouse chromosome 18. Mamm Genome 1994; 5:333-6.
39. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML, Lamb BT, Deng JM, Behringer RR, Capel B, Rubin EM, Nadeau JH and Matin A. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 2005; 435:360-4.
40. Mehta A, Kinter MT, Sherman NE and Driscoll DM. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 2000; 20:1846-54.
41. Wedekind JE, Dance GSC, Sowden MP and Smith HC. Messenger RNAediting in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet 2003; 19:207-16.
42. Keegan LP, Gallo A and O'Connell MA. The many roles of an RNA editor. Nat Rev Genetics 2001; 2:869-78.